Importantly, this is independent of peripheral IFN-α blood concentrations in individuals with AGS, indicating a CNS-dominant disease driven by local neurotoxic levels of IFN-α (Viengkhou et al., 2024b). This evidence concerns the gene IFNA1 and Aicardi-Goutieres syndrome.